Medicare Enrolled
Dr. Parag Majmudar, MD
Ophthalmology · Highland Park, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Majmudar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Majmudar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Majmudar
Dr. Parag Majmudar is an ophthalmology specialist in Highland Park, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Majmudar performed 2,736 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Majmudar received a total of $403,546 from 43 pharmaceutical and/or device companies across 711 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Majmudar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 39% volume in IL
$403,546 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,736
Medicare services
Top 39% in IL for ophthalmology
Not available
Unique patients (not deduplicated)
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
830 | $89 | $250 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
279 | $66 | $177 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
234 | $32 | $192 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
228 | $408 | $3,000 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
223 | $105 | $335 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
185 | $8 | $140 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
179 | $26 | $95 |
| Slit lamp examination of the eye This procedure uses a specialized microscope to examine the front portion of the eye. |
151 | $29 | $370 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
128 | $28 | $298 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
82 | $26 | $300 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
80 | $267 | $1,050 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
62 | $45 | $205 |
| Corneal transplant, outer layer Surgical procedure to replace the outer layer of the cornea with donor tissue. |
25 | $991 | $4,000 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
19 | $591 | $3,425 |
| New patient eye exam, problem focused A focused examination of the visual system performed during a new patient visit. |
19 | $64 | $185 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
12 | $29 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.2% high complexity
21.0% medium
69.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$403,546
Total received (2018-2024)
Avg $57,649/year across 7 years
Top 2% in IL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
711
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$54,090
2023
$60,529
2022
$37,850
2021
$46,620
2020
$14,427
2019
$125,055
2018
$64,977
Payments by company (2024)
Dompe US, Inc.
$18,374
Bausch & Lomb Americas Inc.
$14,894
SUN PHARMACEUTICAL INDUSTRIES INC.
$9,967
Alcon Vision LLC
$6,872
Alcon Research LLC
$1,500
Glaukos Corporation
$1,165
Johnson & Johnson Surgical Vision, Inc.
$281
RxSight Inc
$261
Carl Zeiss Meditec USA, Inc.
$241
Harrow Eye, LLC
$161
Tarsus Pharmaceuticals, Inc.
$134
Haag-Streit USA, Inc.
$107
Topcon Healthcare, Inc.
$95
Oyster Point Pharma, Inc.
$20
NEW WORLD MEDICAL,INC.
$19
Top 3 companies account for 79.9% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$64,703
Bausch & Lomb, a division of Bausch Health US, LLC
$61,909
Shire North American Group Inc
$48,048
Dompe US, Inc.
$45,154
Kala Pharmaceuticals, Inc.
$39,786
Sun Pharmaceutical Industries Inc.
$25,741
Alcon Laboratories Inc
$24,761
Novartis Pharmaceuticals Corporation
$22,296
Eyevance Pharmaceuticals LLC
$16,091
Alcon Vision LLC
$14,851
SUN PHARMACEUTICAL INDUSTRIES INC.
$14,154
Carl Zeiss Meditec, Inc.
$8,885
Glaukos Corporation
$3,084
Allergan Inc.
$2,818
Alcon Research LLC
$2,200
RECORDATI_RARE_DISEASES_INC.
$2,021
TissueTech, Inc.
$1,524
Johnson & Johnson Surgical Vision, Inc.
$1,502
Carl Zeiss Meditec USA, Inc.
$1,396
Ocular Therapeutix, Inc.
$457
RxSight Inc
$405
Oyster Point Pharma, Inc.
$367
Allergan, Inc.
$225
Harrow Eye, LLC
$161
Tarsus Pharmaceuticals, Inc.
$134
NEW WORLD MEDICAL,INC.
$112
Haag-Streit USA, Inc.
$107
Topcon Healthcare, Inc.
$95
Quidel Corporation
$88
Omeros Corporation
$75
NOVARTIS PHARMACEUTICALS CORPORATION
$50
EYEVANCE PHARMACEUTICALS LLC
$50
Mallinckrodt Hospital Products Inc.
$46
ABBVIE INC.
$45
Aerie Pharmaceuticals, Inc.
$39
Kowa Research Institute, Inc.
$27
Ivantis, Inc
$27
Horizon Therapeutics plc
$23
ALK-Abello, Inc
$23
TearLab Corp
$20
Rayner Intraocular Lenses Limited
$18
EyePoint Pharmaceuticals US, Inc.
$16
TISSUETECH, INC.
$11
Top 3 companies account for 43.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ARGOS · ARTEVO 800 · AcrySof · AcrySof IQ PanOptix UV IOL · Ahmed Glaucoma Valve · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CE-marked KXLA system · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · CIRRUS HD-OCT · Cataract Suite · Centurion · Cequa · Clareon · Compact Intuitiv · DEXTENZA · DEXYCU · DOCTORS ALLERGY FORMULA · DUREZOL · DURYSTA · EYSUVIS · Flarex · Hydrus · INVELTYS · IOLMaster 500 · IOLMaster 700 · InflammaDry · KXL System · KXL system (not refurbished) · Kahook Dual Blade · LOTEMAX GEL · LOTEMAX SM · LenSx · Luxor · MIEBO · OPHTHALMIC INSTRUMENTS · OXERVATE · OZURDEX · Odactra · Omidria · Oxervate · PROKERA · PROLENSA · Photrexa · Prokera · QUATERA 700 · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · ReSure Sealant · Rocklatan · SCOUTPRO · STELLARIS · STELLARIS ELITE · STELLARIS PC · TECNIS IOL · TEPEZZA · TYRVAYA · Tecnis Simplicity · Tecnis Symfony IOL · TobraDex ST · Tobradex ST · VERACITY SURGICAL · VEVYE · VUITY · VYZULTA · VisuMax · Wavelight · XDEMVY · XELPROS · XIIDRA · ZYLET · Zerviate · enVista MX60 IOL · iStent inject Trabecular Micro-Bypass System Model G2-M-IS · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
484
County median income
$108,917
Nearest hospital to ZIP centroid (approximate)
NORTHWESTERN LAKE FOREST HOSPITAL
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Majmudar is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Majmudar experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Majmudar performed 830 comprehensive eye exam, established patient services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Majmudar receive payments from pharmaceutical companies?
Yes. Dr. Majmudar received a total of $403,546 from 43 companies across 711 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Majmudar's costs compare to other ophthalmologists in Highland Park?
Dr. Majmudar's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Majmudar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Highland Park
Browse ophthalmologists in Highland Park ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in IL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in IL
Which IL ophthalmologists receive the most from drug and device companies.
By company
Bausch & Lomb Americas Inc. Payments to Doctors
See all physicians who received payments from Bausch & Lomb Americas Inc.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
By company
Shire North American Group Inc Payments to Doctors
See all physicians who received payments from Shire North American Group Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology